STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8
Clinical trials for STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo targets Hard-to-Treat HER2 cancers
Disease control OngoingThis early-phase trial is testing a combination of two drugs—trastuzumab deruxtecan (a targeted chemotherapy) and ceralasertib (a drug that may block cancer cell repair)—in people with advanced solid tumors that have a HER2 mutation. The study has two parts: first, finding the sa…
Matched conditions: STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise for rare salivary gland cancer
Disease control OngoingThis study tests a combination of two drugs—pemetrexed (chemotherapy) and pembrolizumab (immunotherapy)—in people with salivary gland cancer that has returned or spread. The goal is to see if this combo can shrink tumors or slow the disease. About 45 adults with advanced salivary…
Matched conditions: STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC